Scarica l'app Stockscreener
11.75
0.00%
0.00
Dopo l'orario di chiusura:
11.65
-0.10
-0.85%
Precedente Chiudi:
$11.75
Aprire:
$11.7
Volume 24 ore:
155.95K
Relative Volume:
1.30
Capitalizzazione di mercato:
$100.10M
Reddito:
$153.73M
Utile/perdita netta:
$-106.79M
Rapporto P/E:
-6.6011
EPS:
-1.78
Flusso di cassa netto:
$-115.93M
1 W Prestazione:
+1.56%
1M Prestazione:
+38.32%
6M Prestazione:
+49.78%
1 anno Prestazione:
-39.74%
Intervallo 1D:
$11.14
$11.99
Intervallo di 1 settimana:
$10.15
$12.32
Portata 52W:
$5.231
$21.50
Sutro Biopharma Inc Stock (STRO) Company Profile
Nome
Sutro Biopharma Inc
Settore
Industria
Telefono
650-392-8412
Indirizzo
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Confronta STRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
11.75 | 100.10M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-16 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-03-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-05-08 | Iniziato | BofA Securities | Buy |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-06 | Iniziato | Oppenheimer | Outperform |
| 2023-03-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | Ripresa | Wells Fargo | Overweight |
| 2021-06-18 | Iniziato | H.C. Wainwright | Buy |
| 2020-12-03 | Iniziato | Stifel | Buy |
| 2020-09-02 | Iniziato | Jefferies | Buy |
| 2020-07-16 | Iniziato | Wells Fargo | Overweight |
| 2020-01-13 | Iniziato | SunTrust | Buy |
| 2019-10-07 | Iniziato | BTIG Research | Buy |
| 2019-07-18 | Iniziato | Deutsche Bank | Buy |
| 2019-04-29 | Iniziato | H.C. Wainwright | Buy |
| 2018-10-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-10-22 | Iniziato | Piper Jaffray | Overweight |
| 2018-10-22 | Iniziato | Wedbush | Outperform |
Mostra tutto
Sutro Biopharma Inc Borsa (STRO) Ultime notizie
Is Sutro Biopharma Inc. stock supported by strong cash flowsJuly 2025 Analyst Calls & Capital Efficiency Focused Ideas - ulpravda.ru
Is Sutro Biopharma Inc. stock a buy for dividend growth2025 Bull vs Bear & Precise Buy Zone Identification - ulpravda.ru
Is Sutro Biopharma Inc. stock undervalued vs historical averagesProfit Target & Risk Controlled Daily Plans - ulpravda.ru
Will Sutro Biopharma Inc. stock benefit from sector rotationInflation Watch & Consistent Return Strategy Ideas - ulpravda.ru
How risky is Sutro Biopharma Inc. stock nowJuly 2025 News Drivers & AI Enhanced Trade Execution Alerts - ulpravda.ru
Why millennials buy Sutro Biopharma Inc. (S09) stock2025 Dividend Review & Precise Swing Trade Alerts - ulpravda.ru
Sutro Biopharma, Inc. to Present at 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026 - Quiver Quantitative
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Sutro Biopharma lays off dozens of employees in ‘strategic portfolio review’ - MSN
Growth Report: What consensus target says about Sutro Biopharma Inc S09 stockQuarterly Trade Report & Risk Adjusted Buy and Sell Alerts - moha.gov.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of “Hold” by Analysts - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Treasury Yields: Can Sutro Biopharma Inc stock beat analyst upgradesGlobal Markets & Growth Focused Entry Reports - moha.gov.vn
Sutro Biopharma, Inc.'s (NASDAQ:STRO) Price Is Right But Growth Is Lacking After Shares Rocket 46% - simplywall.st
Sutro Biopharma (NASDAQ:STRO) Will Have To Spend Its Cash Wisely - Yahoo Finance
Sutro Biopharma, Inc. (NASDAQ:STRO) Held Back By Insufficient Growth Even After Shares Climb 46% - 富途牛牛
Sutro Biopharma Stock Pre-Market (+6.9%): Momentum From Analyst EPS Upgrade - Trefis
Sutro Biopharma FY2025 EPS Forecast Boosted by HC Wainwright - Defense World
FY2025 EPS Estimate for Sutro Biopharma Increased by Analyst - MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 85.9% in December - MarketBeat
Sutro Biopharma (NASDAQ:STRO) Given New $10.00 Price Target at HC Wainwright - Defense World
HC Wainwright Forecasts Strong Price Appreciation for Sutro Biopharma (NASDAQ:STRO) Stock - MarketBeat
STRO: HC Wainwright Raises Price Target by 400% Today | STRO Sto - GuruFocus
HC Wainwright & Co. Maintains Sutro Biopharma (STRO) Neutral Recommendation - Nasdaq
Is Sutro Biopharma Inc. stock a contrarian buyQuarterly Trade Summary & High Accuracy Investment Entry Signals - Улправда
How rising interest rates impact Sutro Biopharma Inc. stockJuly 2025 Analyst Calls & Expert Verified Stock Movement Alerts - Улправда
Can Sutro Biopharma Inc. stock continue upward trendQuarterly Profit Report & Accurate Buy Signal Alerts - Улправда
Aug Rallies: Why Sutro Biopharma Inc stock is trending among retail tradersPortfolio Update Summary & Growth Oriented Trading Recommendations - moha.gov.vn
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - marketscreener.com
Why Sutro Biopharma Inc. (S09) stock benefits from AI revolutionM&A Rumor & Risk Controlled Daily Plans - DonanımHaber
Is Sutro Biopharma Inc. stock cheap at current valuationQuarterly Risk Review & Free Technical Pattern Based Buy Signals - DonanımHaber
Bear Alert: Is Sutro Biopharma Inc. stock a contrarian buyPortfolio Return Summary & AI Powered Market Entry Ideas - ulpravda.ru
Is Sutro Biopharma Inc. (S09) stock ideal for retirement investorsWeekly Trend Summary & Stepwise Entry and Exit Trade Signals - Улправда
Sutro Biopharma regains Nasdaq compliance after meeting minimum bid price - Investing.com Australia
Sutro Biopharma regains Nasdaq compliance after reverse stock split - Investing.com India
Sutro Biopharma regains Nasdaq compliance after meeting minimum bid price By Investing.com - Investing.com South Africa
Sutro Biopharma Regains Nasdaq Listing Compliance - TipRanks
Sutro Biopharma regains Nasdaq compliance after reverse stock split By Investing.com - Investing.com South Africa
Sutro Biopharma Regains Nasdaq Compliance - TradingView — Track All Markets
[8-K] SUTRO BIOPHARMA, INC. Reports Material Event | STRO SEC FilingForm 8-K - Stock Titan
Free cash flow per share of Sutro Biopharma, Inc. – MUN:S090 - TradingView — Track All Markets
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times
Sutro Biopharma Regains Nasdaq Compliance Following Reverse Stock Split - Quiver Quantitative
Deutsche Bank Boosts Price Target on Sutro Biopharma to $51 From $5, Keeps Buy Rating - marketscreener.com
Sutro Biopharma regains NASDAQ listing compliance - MSN
CEO Chung Acquires 1,606 Of Sutro Biopharma Inc [STRO] - TradingView — Track All Markets
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates - MSN
Net margin % of Sutro Biopharma, Inc. – FWB:S090 - TradingView — Track All Markets
Sutro Biopharma Earnings Notes - Trefis
Sutro Biopharma Inc Azioni (STRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):